[Individualising antihypertensive therapy in patients with diabetes. A guideline by the Austrian Diabetes Association (Update 2019)].

Schernthaner, Guntram; Saely, Christoph H; Schernthaner, Gerit-Holger; Watschinger, Bruno; Drexel, Heinz (2019). [Individualising antihypertensive therapy in patients with diabetes. A guideline by the Austrian Diabetes Association (Update 2019)]. Wiener klinische Wochenschrift, 131(Suppl 1), pp. 124-135. Springer-Verlag 10.1007/s00508-019-1460-2

Preview

Text SchernthanerG_IndividualisierungderantihypertensivenTherapie_WienKlinWochenschr.pdf - Published Version Available under License Creative Commons: Attribution (CC-BY). Download (475kB) | Preview

Hypertension is one of the most important comorbidities of diabetes, contributing significantly to death and leads to macrovascular and microvascular complications. When assessing the medical priorities for patients with diabetes, treating hypertension should be a primary consideration. In the present review practical approaches to hypertension in diabetes, including individualized targets for preventing specific complications are discussed according to current studies and guidelines. According to recent studies, blood pressure values of about 130/80 mm Hg are associated with the best outcome. Angiotensin converting enzyme inhibitors and angiotensin receptor blockers are the most effective drugs for treating hypertension in diabetes. Calcium antagonists or diuretics are acceptable as second-line agents. Once the target is achieved, antihypertensive drugs should be continued. Newer antidiabetic medications such as SGLT-2-inhibitors or GLP1-receptor agonists have also antihypertensive effects.

Interest & Impact

Downloads

162 since deposited on 13 Dec 2019
39 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item